BR112015003058A2 - derivados bicíclicos de heteroaril cicloalquildiamina como inibidores de tirosina quinases do baço (syk) - Google Patents

derivados bicíclicos de heteroaril cicloalquildiamina como inibidores de tirosina quinases do baço (syk)

Info

Publication number
BR112015003058A2
BR112015003058A2 BR112015003058A BR112015003058A BR112015003058A2 BR 112015003058 A2 BR112015003058 A2 BR 112015003058A2 BR 112015003058 A BR112015003058 A BR 112015003058A BR 112015003058 A BR112015003058 A BR 112015003058A BR 112015003058 A2 BR112015003058 A2 BR 112015003058A2
Authority
BR
Brazil
Prior art keywords
syk
tyrosine kinases
spleen tyrosine
bicyclic derivatives
heteroaryl cycloalkyl
Prior art date
Application number
BR112015003058A
Other languages
English (en)
Portuguese (pt)
Inventor
Baxter Smith Alexander
Thoma Gebhard
Van Eis Maurice
Buehlmayer Peter
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BR112015003058A2 publication Critical patent/BR112015003058A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • A61K31/5025Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BR112015003058A 2012-08-13 2013-08-12 derivados bicíclicos de heteroaril cicloalquildiamina como inibidores de tirosina quinases do baço (syk) BR112015003058A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261682392P 2012-08-13 2012-08-13
PCT/IB2013/056589 WO2014027300A1 (en) 2012-08-13 2013-08-12 Bicyclic heteroaryl cycloalkyldiamine derivatives as inhibitors of spleen tyrosine kinases (syk)

Publications (1)

Publication Number Publication Date
BR112015003058A2 true BR112015003058A2 (pt) 2017-07-04

Family

ID=49385306

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112015003058A BR112015003058A2 (pt) 2012-08-13 2013-08-12 derivados bicíclicos de heteroaril cicloalquildiamina como inibidores de tirosina quinases do baço (syk)

Country Status (14)

Country Link
US (2) US9315500B2 (https=)
EP (1) EP2882747B1 (https=)
JP (1) JP6236083B2 (https=)
KR (1) KR20150042256A (https=)
CN (1) CN104520297B (https=)
AU (1) AU2013303824B2 (https=)
BR (1) BR112015003058A2 (https=)
CA (1) CA2880790C (https=)
EA (1) EA201590372A1 (https=)
ES (1) ES2576692T3 (https=)
HK (1) HK1209421A1 (https=)
IN (1) IN2015DN00950A (https=)
MX (1) MX2015002006A (https=)
WO (1) WO2014027300A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104520297B (zh) * 2012-08-13 2016-08-24 瑞士诺华动物保健有限公司 作为肾酪氨酸激酶抑制剂的双环杂芳基环烷基二胺衍生物
EA202192575A1 (ru) 2019-03-21 2022-01-14 Онксео Соединения dbait в сочетании с ингибиторами киназ для лечения рака
CN114761006A (zh) 2019-11-08 2022-07-15 Inserm(法国国家健康医学研究院) 对激酶抑制剂产生耐药性的癌症的治疗方法
WO2021148581A1 (en) 2020-01-22 2021-07-29 Onxeo Novel dbait molecule and its use
CN119173446A (zh) 2022-03-08 2024-12-20 赤盾医疗有限公司 机器人药物制备系统中的流体转移站

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1524747A (en) 1976-05-11 1978-09-13 Ici Ltd Polypeptide
ATE28864T1 (de) 1982-07-23 1987-08-15 Ici Plc Amide-derivate.
GB9721069D0 (en) 1997-10-03 1997-12-03 Pharmacia & Upjohn Spa Polymeric derivatives of camptothecin
JP2007524596A (ja) 2003-02-28 2007-08-30 トランスフォーム・ファーマシューティカルズ・インコーポレイテッド 共結晶医薬組成物
KR100781704B1 (ko) 2005-04-20 2007-12-03 에스케이케미칼주식회사 피리딘 유도체와 이의 제조방법, 및 이를 포함하는약제조성물
CN101405001A (zh) 2006-03-20 2009-04-08 霍夫曼-拉罗奇有限公司 抑制btk和syk蛋白质激酶的方法
TW200938542A (en) * 2008-02-01 2009-09-16 Irm Llc Compounds and compositions as kinase inhibitors
US8722692B2 (en) * 2009-07-30 2014-05-13 Jianwei Che Compounds and compositions as Syk kinase inhibitors
TW201105669A (en) 2009-07-30 2011-02-16 Irm Llc Compounds and compositions as Syk kinase inhibitors
MX2012004846A (es) 2009-10-29 2012-10-05 Genosco Inhibidores de cinasa.
WO2012097479A1 (en) * 2011-01-21 2012-07-26 Abbott Laboratories Bicyclic inhibitors of anaphastic lymphoma kinase
CN104520297B (zh) * 2012-08-13 2016-08-24 瑞士诺华动物保健有限公司 作为肾酪氨酸激酶抑制剂的双环杂芳基环烷基二胺衍生物

Also Published As

Publication number Publication date
IN2015DN00950A (https=) 2015-06-12
CA2880790A1 (en) 2014-02-20
CA2880790C (en) 2020-09-08
KR20150042256A (ko) 2015-04-20
WO2014027300A1 (en) 2014-02-20
JP2015524838A (ja) 2015-08-27
EP2882747B1 (en) 2016-04-27
CN104520297B (zh) 2016-08-24
AU2013303824B2 (en) 2016-03-31
JP6236083B2 (ja) 2017-11-22
EA201590372A1 (ru) 2015-05-29
AU2013303824A1 (en) 2015-02-26
EP2882747A1 (en) 2015-06-17
US9315500B2 (en) 2016-04-19
MX2015002006A (es) 2015-06-02
US20150218157A1 (en) 2015-08-06
HK1209421A1 (en) 2016-04-01
ES2576692T3 (es) 2016-07-08
US20160213670A1 (en) 2016-07-28
CN104520297A (zh) 2015-04-15

Similar Documents

Publication Publication Date Title
IL265007B (en) Pyrazolopyrimidine compounds as kinase inhibitors
BR112015003218A2 (pt) pirazolil-ureias como inibidores de cinase
EP2912019A4 (en) HETEROARYL HEMMER OF PDE4
ZA201600648B (en) Novel pyrrolopyrimidine compounds as inhibitors of protein kinases
IL238693A0 (en) Substituted tricyclic benzimidazoles as kinase inhibitors
BR112013008527A2 (pt) derivados de pirazolo-quinazolina substituídos como inibidores de cinase
IL239628A0 (en) Azaindole derivatives as inhibitors of protein kinases
EP2916836A4 (en) AMINOPYRIDE-CONTAINING MILK TYROSINE KINASE (SYK) INHIBITOR
SI2880035T1 (sl) Nove spojine pirolopirimidina kot inhibitorji protein kinaz
EP2925325A4 (en) STABILIZED FORMULATION OF PEMETREXED
EP2880038A4 (en) PROTEIN KINASE INHIBITORS
CO6791612A2 (es) Piridinilo- y pirazinilo-metiloxi - arilo derivados útiles como inhibidores de tirosina quinasa del bazo (syk)
ZA201401013B (en) Novel imidazole amines as modulators of kinase activity
EP2948456A4 (en) BICYCLIC PYRIMIDONE COMPOUNDS AS LP-PLA2 INHIBITORS
BR112015003058A2 (pt) derivados bicíclicos de heteroaril cicloalquildiamina como inibidores de tirosina quinases do baço (syk)
EP2900243A4 (en) BICYCLIC OXA LACTAM KINASE HEMMER
HRP20190390T1 (hr) Postupak za pripremanje oksikodona
EP2922823A4 (en) PDE10 PYRIMIDININHIBITOREN
ES2390324B8 (es) Juego de brocas

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law
B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)